On June 24, 2024, Sun Pharmaceutical Industries Limited announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd (Taro) with its subsidiary. Sun Pharma, which has been the majority shareholder of Taro since 2010, acquired all outstanding ordinary shares of Taro that are not already owned by itself or its affiliates. Following the …